Susan Molineaux

Susan Molineaux

Founder presso CALITHERA BIOSCIENCES, INC.

Patrimonio netto: 431 625 $ in data 31/03/2024

70 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Susan M.
Molineaux
was the founder of Proteolix, Inc. (founded in 2003) and Calithera Biosciences, Inc. (founded in 2010), where she holds the title of Chief Scientific Officer and President, Chief Executive Officer & Director respectively.
She currently holds the position of Independent Director at Geron Corp.
(since 2012), Repare Therapeutics, Inc. (since 2023), and Smith College (since 2017).
She is also a Scientific Advisor at LSV Capital Management LLC.
In her former roles, she served as Co-Vice Chairman at The Bay Area Bioscience Association, Independent Director at Theravance Biopharma, Inc. (from 2015 to 2022), Secretary & Director at We Teach Science Foundation, Director at California Biomedical Innovation Alliance, Independent Director at Cyteir Therapeutics, Inc. (from 2020 to 2023), Director at California Life Sciences Association, Scientist-Immunology Group at Merck & Co., Inc. (from 1989 to 1994), Vice President-Drug Development at Praecis Pharmaceuticals, Inc. (from 1994 to 1999), Vice President-Biology at Rigel Pharmaceuticals, Inc. (from 2000 to 2003), and Vice President-Biology at Praelux, Inc. (from 1999 to 2000).
She obtained her undergraduate degree from Smith College and her doctorate degree from The Johns Hopkins University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
01/03/2024 130 527 ( 0.02% ) 430 739 $ 31/03/2024
30/04/2023 35 441 ( 0.73% ) 886 $ 31/03/2024
08/06/2023 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Susan Molineaux

SocietàPosizioneInizio
GERON CORPORATION Director/Board Member 28/09/2012
CALITHERA BIOSCIENCES, INC. Founder 09/03/2010
REPARE THERAPEUTICS INC. Director/Board Member 08/06/2023
Director/Board Member 01/06/2017
Consultant / Advisor -
Tutte le posizioni attive di Susan Molineaux

Precedenti posizioni note di Susan Molineaux

SocietàPosizioneFine
CYTEIR THERAPEUTICS, INC. Director/Board Member 26/05/2023
THERAVANCE BIOPHARMA, INC. Director/Board Member 01/01/2022
Director/Board Member 01/03/2016
Director/Board Member 01/03/2016
░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Susan Molineaux

Formazione di Susan Molineaux

Smith College Undergraduate Degree
The Johns Hopkins University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Susan Molineaux

Relazioni

100 +

Relazioni di 1° grado

17

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa7
MERCK & CO., INC.

Health Technology

GERON CORPORATION

Health Technology

RIGEL PHARMACEUTICALS, INC.

Health Technology

CALITHERA BIOSCIENCES, INC.

Health Technology

THERAVANCE BIOPHARMA, INC.

Health Technology

CYTEIR THERAPEUTICS, INC.

Health Technology

REPARE THERAPEUTICS INC.

Health Technology

Aziende private8

Health Technology

Health Technology

Health Technology

The Bay Area Bioscience Association

Health Technology

We Teach Science Foundation

Health Technology

Commercial Services

Finance

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Susan Molineaux